Enfusion

Enfusion EV/FCF

Delisted

The EV/FCF (Enterprise Value to Free Cash Flow) of Enfusion (ENFN) as of Nov 7, 2026 is 43.25. In the previous year, EV/FCF (Enterprise Value to Free Cash Flow) was 85.29 — a change of -49.30% (lower).

EV/FCF

43.25

YoY

-49.30%

Last updated:

EV/FCF (Enterprise Value to Free Cash Flow) of Enfusion is 2024 43.25 . EV/FCF (Enterprise Value to Free Cash Flow) of Enfusion was 2023 85.29 . It decreases by -49.30% lower compared to the previous year.

The Enfusion EV/FCF history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

EV/FCF
Date
EV/FCF
Jan 1, 2019
180.14 USD
Jan 1, 2020
-435.45 USD
Jan 1, 2021
-159.96 USD
Jan 1, 2022
214.40 USD
Jan 1, 2023
85.29 USD
Jan 1, 2024
43.25 USD
The Enfusion EV/FCF history
YEAREV/FCFYoY
43.25-49.30%
85.29-60.22%
214.40-234.03%
-159.96-63.27%
-435.45-341.73%
180.14—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Enfusion Stock analysis

What does Enfusion do? Enfusion Inc. generates revenue through cloud-native multi-tenant software solutions tailored for alternative and institutional investment managers. Its core products include the Portfolio Management System (PMS), Order and Execution Management System (OEMS), Accounting/General Ledger System, and Enfusion Analytics System, which collectively enable real-time investment decision-making. The company serves investment managers who require integrated systems for the full investment lifecycle, with PMS constructing and rebalancing portfolios while generating a real-time investment book of record, and OEMS facilitating electronic trade order communication for portfolio managers, traders, compliance teams, and analysts. The company's solution integrates technology-powered managed services to drive insights and control over investment operations. Enfusion's end-to-end functionality supports the entire investment process, from portfolio construction to trade execution, with PMS and OEMS operating in tandem to provide a seamless workflow. Investment managers across alternative and institutional segments purchase these integrated systems to enhance operational efficiency and decision-making capabilities. Enfusion's software is designed to serve the full investment lifecycle, with its systems integrated to provide a unified platform for portfolio management, order execution, accounting, and analytics. The company's revenue model is based on delivering these comprehensive solutions to investment managers who rely on real-time data and integrated workflows to manage their operations effectively. Enfusion is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Enfusion stock

EV/FCF (Enterprise Value to Free Cash Flow) of Enfusion is 43.25 in 2024.

EV/FCF (Enterprise Value to Free Cash Flow) of Enfusion changed from 85.29 to 43.25, representing a -49.30% change. The value is lower than the previous year.

On Eulerpool you can find the complete historical development of EV/FCF (Enterprise Value to Free Cash Flow) Enfusion since 2006 – with annual values, charts, and detailed analysis.

The EV/FCF ratio measures the enterprise value relative to free cash flow. It captures the true cash-generating ability of a business.

To evaluate EV/FCF (Enterprise Value to Free Cash Flow)'s, it is essential to compare it with peers in the same industry and sector. On Eulerpool, you can find direct industry comparisons for EV/FCF (Enterprise Value to Free Cash Flow).

A 'good' varies by industry and company stage. On Eulerpool, you can compare EV/FCF (Enterprise Value to Free Cash Flow)'s Enfusion with sector peers and the industry average to assess whether it is attractive.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Valuation — Enfusion

All Key Metrics — Enfusion